health MIT’s Injectable ‘Satellite Livers’ Show 2-Month Viability in Mice, Offering Hope for Patients Beyond Transplant Lists
MIT researchers developed injectable hydrogel-encased hepatocytes that functioned as mini-livers in mice, surviving two months. The technology could provide a bridge or alternative to organ transplantation for chronic liver failure patients, especially those too frail for surgery.
